- This event has passed.
Meeting | Topic: Presentation on Vyalev, the first and only subcutaneous levodopa-based therapy | Speaker: Christina Mayo
The presentation will be about Vyalev, the first and only subcutaneous levodopa-based therapy.
Replaces all oral carbidopa/levodopa and COMT inhibitors
Drug/device combo that gives 24-hour continuous delivery of carbidopa/levodopa
Gives patients superior “on” time vs. oral medication
No surgical procedure required
Our speaker will be Christina Mayo.
Christina Mayo is an Account Executive with Abbvie Neuroscience based in Greenville SC. She received her BS in Biological Sciences at the University of South Carolina in 2010. Christina has been in the medical sales industry since 2010, specifically in the Parkinson’s Disease space since 2016.
Contact: Christina N. Mayo, Parkinson’s Account Executive, South Carolina & S. Georgia
AbbVie Neuroscience
Office : 1 (864) 982-6940
EMAIL : christina.mayo@abbvie.com